Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

August 2018 | 120 pages | ID: GF019EB3EDAGEN
GlobalInfoResearch

Abstracts

Gastroesophageal reflux disease (GERD), also known as acid reflux, is a long-term condition where stomach contents come back up into the esophagus resulting in either symptoms or complications.

SCOPE OF THE REPORT:

This report studies the Gastroesophageal Reflux Disease (GERD) Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Gastroesophageal Reflux Disease (GERD) Therapeutics market by product type and applications/end industries.
Patent expiry of blockbuster drugs prescribed for the treatment of acid reflux disorders is majorly attributable for the downfall of this market.
The global Gastroesophageal Reflux Disease (GERD) Therapeutics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Gastroesophageal Reflux Disease (GERD) Therapeutics.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers

• AstraZeneca
• Eisai
• GSK
• Takeda
• Johnson & Johnson

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Antacids
• Pro-kinetic agents
• H2 Receptor Blockers
• Proton Pump Inhibitors (PPIs)

Market Segment by Applications, can be divided into

• Heartburn
• Acid reflux disorders

Contents

1 GASTROESOPHAGEAL REFLUX DISEASE (GERD) THERAPEUTICS MARKET OVERVIEW

1.1 Product Overview and Scope of Gastroesophageal Reflux Disease (GERD) Therapeutics
1.2 Classification of Gastroesophageal Reflux Disease (GERD) Therapeutics by Types
  1.2.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Comparison by Types (2017-2023)
  1.2.2 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Types in 2017
  1.2.3 Antacids
  1.2.4 Pro-kinetic agents
  1.2.5 H2 Receptor Blockers
  1.2.6 Proton Pump Inhibitors (PPIs)
1.3 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market by Application
  1.3.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Heartburn
  1.3.3 Acid reflux disorders
1.4 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market by Regions
  1.4.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Gastroesophageal Reflux Disease (GERD) Therapeutics Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Gastroesophageal Reflux Disease (GERD) Therapeutics Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Gastroesophageal Reflux Disease (GERD) Therapeutics Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Gastroesophageal Reflux Disease (GERD) Therapeutics Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Gastroesophageal Reflux Disease (GERD) Therapeutics Status and Prospect (2013-2023)
1.5 Global Market Size of Gastroesophageal Reflux Disease (GERD) Therapeutics (2013-2023)

2 MANUFACTURERS PROFILES

2.1 AstraZeneca
  2.1.1 Business Overview
  2.1.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 AstraZeneca Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.2 Eisai
  2.2.1 Business Overview
  2.2.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Eisai Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.3 GSK
  2.3.1 Business Overview
  2.3.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 GSK Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.4 Takeda
  2.4.1 Business Overview
  2.4.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Takeda Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.5 Johnson & Johnson
  2.5.1 Business Overview
  2.5.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Johnson & Johnson Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL GASTROESOPHAGEAL REFLUX DISEASE (GERD) THERAPEUTICS MARKET COMPETITION, BY PLAYERS

3.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Gastroesophageal Reflux Disease (GERD) Therapeutics Players Market Share
  3.2.2 Top 10 Gastroesophageal Reflux Disease (GERD) Therapeutics Players Market Share
3.3 Market Competition Trend

4 GLOBAL GASTROESOPHAGEAL REFLUX DISEASE (GERD) THERAPEUTICS MARKET SIZE BY REGIONS

4.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Market Share by Regions
4.2 North America Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2013-2018)
4.3 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2013-2018)
4.5 South America Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE (GERD) THERAPEUTICS REVENUE BY COUNTRIES

5.1 North America Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue by Countries (2013-2018)
5.2 USA Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2013-2018)
5.3 Canada Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2013-2018)
5.4 Mexico Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2013-2018)

6 EUROPE GASTROESOPHAGEAL REFLUX DISEASE (GERD) THERAPEUTICS REVENUE BY COUNTRIES

6.1 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue by Countries (2013-2018)
6.2 Germany Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2013-2018)
6.3 UK Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2013-2018)
6.4 France Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2013-2018)
6.5 Russia Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2013-2018)
6.6 Italy Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE (GERD) THERAPEUTICS REVENUE BY COUNTRIES

7.1 Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue by Countries (2013-2018)
7.2 China Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2013-2018)
7.3 Japan Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2013-2018)
7.4 Korea Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2013-2018)
7.5 India Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE (GERD) THERAPEUTICS REVENUE BY COUNTRIES

8.1 South America Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue by Countries (2013-2018)
8.2 Brazil Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2013-2018)
8.3 Argentina Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2013-2018)
8.4 Colombia Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE GASTROESOPHAGEAL REFLUX DISEASE (GERD) THERAPEUTICS BY COUNTRIES

9.1 Middle East and Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue by Countries (2013-2018)
9.2 Saudi Arabia Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2013-2018)
9.3 UAE Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2013-2018)
9.4 Egypt Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2013-2018)
9.5 Nigeria Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2013-2018)
9.6 South Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2013-2018)

10 GLOBAL GASTROESOPHAGEAL REFLUX DISEASE (GERD) THERAPEUTICS MARKET SEGMENT BY TYPE

10.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Market Share by Type (2013-2018)
10.2 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Forecast by Type (2018-2023)
10.3 Antacids Revenue Growth Rate (2013-2023)
10.4 Pro-kinetic agents Revenue Growth Rate (2013-2023)
10.5 H2 Receptor Blockers Revenue Growth Rate (2013-2023)
10.6 Proton Pump Inhibitors (PPIs) Revenue Growth Rate (2013-2023)

11 GLOBAL GASTROESOPHAGEAL REFLUX DISEASE (GERD) THERAPEUTICS MARKET SEGMENT BY APPLICATION

11.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Application (2013-2018)
11.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Market Forecast by Application (2018-2023)
11.3 Heartburn Revenue Growth (2013-2018)
11.4 Acid reflux disorders Revenue Growth (2013-2018)

12 GLOBAL GASTROESOPHAGEAL REFLUX DISEASE (GERD) THERAPEUTICS MARKET SIZE FORECAST (2018-2023)

12.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Forecast (2018-2023)
12.2 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Forecast by Regions (2018-2023)
12.3 North America Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Forecast (2018-2023)
12.4 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Forecast (2018-2023)
12.6 South America Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Gastroesophageal Reflux Disease (GERD) Therapeutics Picture
Table Product Specifications of Gastroesophageal Reflux Disease (GERD) Therapeutics
Table Global Gastroesophageal Reflux Disease (GERD) Therapeutics and Revenue (Million USD) Market Split by Product Type
Figure Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Types in 2017
Figure Antacids Picture
Figure Pro-kinetic agents Picture
Figure H2 Receptor Blockers Picture
Figure Proton Pump Inhibitors (PPIs) Picture
Table Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue (Million USD) by Application (2013-2023)
Figure Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Applications in 2017
Figure Heartburn Picture
Figure Acid reflux disorders Picture
Table Global Market Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Gastroesophageal Reflux Disease (GERD) Therapeutics Type and Applications
Table AstraZeneca Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Eisai Basic Information, Manufacturing Base and Competitors
Table Eisai Gastroesophageal Reflux Disease (GERD) Therapeutics Type and Applications
Table Eisai Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table GSK Basic Information, Manufacturing Base and Competitors
Table GSK Gastroesophageal Reflux Disease (GERD) Therapeutics Type and Applications
Table GSK Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Takeda Basic Information, Manufacturing Base and Competitors
Table Takeda Gastroesophageal Reflux Disease (GERD) Therapeutics Type and Applications
Table Takeda Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Gastroesophageal Reflux Disease (GERD) Therapeutics Type and Applications
Table Johnson & Johnson Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue (Million USD) by Players (2013-2018)
Table Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Share by Players (2013-2018)
Figure Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Share by Players in 2016
Figure Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Share by Players in 2017
Figure Global Top 5 Players Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share in 2017
Figure Global Top 10 Players Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share in 2017
Figure Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue (Million USD) by Regions (2013-2018)
Table Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Regions (2013-2018)
Figure Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Regions (2013-2018)
Figure Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Regions in 2017
Figure North America Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2013-2018)
Figure Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2013-2018)
Figure South America Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2013-2018)
Table North America Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue by Countries (2013-2018)
Table North America Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Countries (2013-2018)
Figure North America Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Countries (2013-2018)
Figure North America Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Countries in 2017
Figure USA Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2013-2018)
Figure Canada Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2013-2018)
Figure Mexico Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2013-2018)
Table Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue (Million USD) by Countries (2013-2018)
Figure Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Countries in 2017
Figure Germany Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2013-2018)
Figure UK Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2013-2018)
Figure France Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2013-2018)
Figure Russia Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2013-2018)
Figure Italy Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Countries in 2017
Figure China Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2013-2018)
Figure Japan Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2013-2018)
Figure Korea Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2013-2018)
Figure India Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2013-2018)
Table South America Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue by Countries (2013-2018)
Table South America Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Countries (2013-2018)
Figure South America Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Countries (2013-2018)
Figure South America Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Countries in 2017
Figure Brazil Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2013-2018)
Figure Argentina Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2013-2018)
Figure Colombia Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Countries in 2017
Figure Saudi Arabia Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2013-2018)
Figure UAE Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2013-2018)
Figure Egypt Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2013-2018)
Figure Nigeria Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2013-2018)
Figure South Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2013-2018)
Table Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue (Million USD) by Type (2013-2018)
Table Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Share by Type (2013-2018)
Figure Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Share by Type (2013-2018)
Figure Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Share by Type in 2017
Table Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Forecast by Type (2018-2023)
Figure Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share Forecast by Type (2018-2023)
Figure Global Antacids Revenue Growth Rate (2013-2018)
Figure Global Pro-kinetic agents Revenue Growth Rate (2013-2018)
Figure Global H2 Receptor Blockers Revenue Growth Rate (2013-2018)
Figure Global Proton Pump Inhibitors (PPIs) Revenue Growth Rate (2013-2018)
Table Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue by Application (2013-2018)
Table Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Share by Application (2013-2018)
Figure Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Share by Application (2013-2018)
Figure Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Share by Application in 2017
Table Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Forecast by Application (2018-2023)
Figure Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share Forecast by Application (2018-2023)
Figure Global Heartburn Revenue Growth Rate (2013-2018)
Figure Global Acid reflux disorders Revenue Growth Rate (2013-2018)
Figure Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Forecast (2018-2023)
Figure Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Forecast (2018-2023)
Figure South America Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Forecast (2018-2023)